DIETARY MOLECULAR DIAGNOSTICS S.L.

Biomeb is a health technology company promoting metabolomics for precision medicine as well as research in other fields of life science, providing new products and services to society that means a breakthrough in the prevention, diagnosis and personalized treatment of different pathologies. Multifunctional Dietary fibre to tackle metabolic syndrome. Fibracep® is a new patented bioactive product based on fibres extracted from natural sources, clinically tested. In several aleatorized, placebo-controlled clinical trials, Fibracep® is effective to modulate the risk of metabolic syndrome development, by acting on several of its components. Well B is conceived as an emerging approach for disease prevention and lifestyle management that considers each person as a whole using metabolomics, anthropometric, biochemical, environmental and lifestyle data to assess cardiovascular health in a personalized manner. Thus, Well B provides precise personal nutritional recommendations based on the metabolic profile for improved health through personalized nutrition.